Dr. Bindu Garg Hospital

Details Doctors
Medical Suppliers In Haryana

Name :

Dr. Bindu Garg Hospital

Address  :

1, Neelkanth Hospital, Main
Mehrauli-Gurgaon Rd, near
Guru Dronacharya Metro
Station DLF Phase 3

Town  :

Gurugram

State  :

Haryana

Country  :

INDIA

Post Code:

122022

Phone  :

7669054615

Web URL  :

Available

Email  :

drbindu@neelkanthhospital.com
Dr Bindu Garg Hospital
Specialization
  • Anaesthesiology
  • Gynaecology
  • Obestetrician/Gynecologist
  • Sonography
  • Specialised Surgery & Obst. & Gynae Treatment.
  • Video Laproscopic Surgery
Facilities

Speciality Type :

  • Single Speciality : Obstetrics And Gynecology

Other Facilities

  • Pathology
  • Ultrasonography

Advance Facility

  • Medicine Facility
Description
Dr Bindu Garg is the best IVF doctor in Gurgaon and the head of the IVF department at Neelkanth Hospitals She has 41 years of remarkable experience in the field of gynecology obstetrics and infertility treatment and was in fact the first IVF specialist in Gurgaon to deliver a baby through IVF treatment Apart from infertility treatments her expertise also lies in normal delivery and she has a high rate of success She has delivered more than 10000 babies through IVF treatment till now She has completed her MBBS and MD from Lady Hardinge Medical College and GB Pant Hospital both situated in New Delhi Dr Garg also has been a consistent recipient of several awards and recognitions such as the Mahatma Gandhi Samman and the Swastha Bharat Samman
NEWS
Stemis hitech aid reaches out to heart attack patients

If you have a heart attack and call the governmentrun EMRI ambulance chances are that you will land up in the care of the most experienced cardiologists in the country A group of doctors here has put together a unique technologypowered System of Care to make sure every heart attack victim in the state gets treated in time Using 3G technology smar... Read More

ARTICLES
Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More